{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:43:09Z","timestamp":1792755789423,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230916-4\"><jats:title>Importance<\/jats:title><jats:p>The impact of nonmedical cannabis legalization on traffic injuries and cannabis involvement in traffic injuries is unclear.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230916-5\"><jats:title>Objective<\/jats:title><jats:p>To examine changes in the number and characteristics of cannabis-involved traffic injury emergency department (ED) visits from before to after legalization and subsequent commercialization (ie, increased retail store and product availability) of cannabis in Ontario, Canada.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230916-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This repeated cross-sectional study examined changes in cannabis- and alcohol-involved traffic injury ED visits in Ontario, Canada, during 3 time periods: prelegalization (January 2010-September 2018), legalization with product and retail store restrictions (October 2018-February 2020), and commercialization with new products and expanded number of stores, which coincided with the COVID-19 pandemic (March 2020-December 2021). All individuals aged 16 years and older eligible for Ontario\u2019s Universal Health Coverage were included. Season- and time-adjusted quasi-Poisson models were used to generate rate ratios with 95% CIs. Data were analyzed from March to April 2023.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230916-7\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Quarterly counts of cannabis-involved ED visits for traffic injury.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230916-8\"><jats:title>Results<\/jats:title><jats:p>There were 947\u202f604 traffic injury ED visits, of which 426 (0.04%) had documented cannabis involvement and 7564 (0.8%) had documented alcohol involvement. Of the 418 individuals with documented cannabis involvement, 330 (78.9%) were male, 109 (25.6%) were aged 16 to 21 years (mean [SD] age at visit, 30.6 [12.0] years), and 113 (27.0%) had an ED visit or hospitalization for substance use in the 2 years before their traffic injury ED visit. Annual rates of cannabis-involved traffic injury ED visits increased 475.3% over the study period (0.18 visits per 1000 total motor vehicle collisions in 2010 to 1.01 in 2021). Over the same period, alcohol-involved traffic injury ED visits increased by 9.4% (8.03 in 2010 to 8.79 per 1000 traffic injury ED visits in 2021). Legalization with restrictions was associated with a 94% increase in the quarterly rate of cannabis involvement in traffic injury ED visits relative to prelegalization (adjusted rate ratio [aRR], 1.94; 95% CI, 1.37-2.75). Commercialization\/COVID-19 was associated with a greater increase of 223% in rates (aRR, 3.23; 95% CI, 2.42-4.33). After adjusting for time trends before legalization, only commercialization\/COVID-19 was associated with increased rates. Male sex (adjusted odds ratio [aOR], 3.38; 95% CI, 2.66-4.29), living in the lowest-income neighborhood (aOR, 1.92; 95% CI, 1.39-2.67), being aged 19 to 21 years (aOR, 4.67; 95% CI, 3.27-6.67), and having a prior cannabis-related ED visit (aOR, 8.03; 95% CI, 5.85-11.02) were all positively associated with cannabis involvement during a traffic injury ED visit.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230916-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This cross-sectional study found large increases in cannabis involvement in ED visits for traffic injury over time, which may have accelerated following nonmedical cannabis commercialization. Although the frequency of visits was rare, they may reflect broader changes in cannabis-impaired driving. Greater prevention efforts, including targeted education and policy measures, in regions with legal cannabis are indicated.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.31551","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T15:04:31Z","timestamp":1694012671000},"page":"e2331551","source":"Crossref","is-referenced-by-count":42,"title":["Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization"],"prefix":"10.1001","volume":"6","author":[{"given":"Daniel T.","family":"Myran","sequence":"first","affiliation":[{"name":"Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Bruy\u00e8re Research Institute, Ottawa, Ontario, Canada"},{"name":"ICES uOttawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Gaudreault","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pugliese","sequence":"additional","affiliation":[{"name":"ICES uOttawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Manuel","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Bruy\u00e8re Research Institute, Ottawa, Ontario, Canada"},{"name":"ICES uOttawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tanuseputro","sequence":"additional","affiliation":[{"name":"Bruy\u00e8re Research Institute, Ottawa, Ontario, Canada"},{"name":"ICES uOttawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"issue":"2","key":"zoi230916r2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/wps.v19.2","article-title":"Assessing the public health impacts of legalizing recreational cannabis use: the US experience.","volume":"19","author":"Hall","year":"2020","journal-title":"World Psychiatry"},{"issue":"8","key":"zoi230916r4","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/add.v118.8","article-title":"High-\u2018n\u2019-dry? a comparison of cannabis and alcohol use in drivers presenting to hospital after a vehicular collision.","volume":"118","author":"Brubacher","year":"2023","journal-title":"Addiction"},{"issue":"8","key":"zoi230916r5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2105\/AJPH.2017.303848","article-title":"Crash fatality rates after recreational marijuana legalization in Washington and Colorado.","volume":"107","author":"Aydelotte","year":"2017","journal-title":"Am J Public Health"},{"issue":"8","key":"zoi230916r6","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jamainternmed.2020.1757","article-title":"Association of recreational cannabis laws in Colorado and Washington state with changes in traffic fatalities, 2005-2017.","volume":"180","author":"Santaella-Tenorio","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"5","key":"zoi230916r7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/add.v114.5","article-title":"Traffic fatalities within US states that have legalized recreational cannabis sales and their neighbours.","volume":"114","author":"Lane","year":"2019","journal-title":"Addiction"},{"issue":"2","key":"zoi230916r8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/ecin.v58.2","article-title":"Early evidence on recreational marijuana legalization and traffic fatalities.","volume":"58","author":"Hansen","year":"2020","journal-title":"Econ Inq"},{"issue":"8","key":"zoi230916r9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/add.v118.8","article-title":"The effect of recreational cannabis legalization on rates of traffic injury in Canada.","volume":"118","author":"Walker","year":"2023","journal-title":"Addiction"},{"key":"zoi230916r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109008","article-title":"Canada\u2019s cannabis legalization and drivers\u2019 traffic-injury presentations to emergency departments in Ontario and Alberta, 2015-2019.","volume":"228","author":"Callaghan","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"zoi230916r11","doi-asserted-by":"publisher","first-page":"E454","DOI":"10.9778\/cmajo.20190012","article-title":"Access to cannabis retail stores across Canada 6 months following legalization: a descriptive study.","volume":"7","author":"Myran","year":"2019","journal-title":"CMAJ Open"},{"issue":"2","key":"zoi230916r12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/dar.v41.2","article-title":"How has access to legal cannabis changed over time? an analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis.","volume":"41","author":"Myran","year":"2022","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"zoi230916r13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/dar.v42.5","article-title":"Access to legal cannabis market in Canada over the four?years following non-medical cannabis legalisation.","volume":"42","author":"Myran","year":"2023","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"zoi230916r14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13017-021-00395-8","article-title":"Global impact of COVID-19 pandemic on road traffic collisions.","volume":"16","author":"Yasin","year":"2021","journal-title":"World J Emerg Surg"},{"issue":"17","key":"zoi230916r15","doi-asserted-by":"publisher","first-page":"E592","DOI":"10.1503\/cmaj.210132","article-title":"The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada.","volume":"193","author":"Brown","year":"2021","journal-title":"CMAJ"},{"issue":"2","key":"zoi230916r16","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.9778\/cmajo.20190154","article-title":"Emergency department use by pregnant women in Ontario: a retrospective population-based cohort study.","volume":"8","author":"Varner","year":"2020","journal-title":"CMAJ Open"},{"key":"zoi230916r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109765","article-title":"Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001-2019).","volume":"244","author":"Imtiaz","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi230916r25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMsa2109371","article-title":"Cannabis legalization and detection of tetrahydrocannabinol in injured drivers.","volume":"386","author":"Brubacher","year":"2022","journal-title":"N Engl J Med"},{"key":"zoi230916r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jth.2021.101123","article-title":"Systematic review of the effects of cannabis retail outlets on traffic collisions, fatalities and other traffic-related outcomes.","volume":"22","author":"Vingilis","year":"2021","journal-title":"J Transp Health"},{"issue":"1","key":"zoi230916r27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15389588.2020.1847281","article-title":"Cannabis, alcohol and other drug findings in fatally injured drivers in Ontario.","volume":"22","author":"Beirness","year":"2021","journal-title":"Traffic Inj Prev"},{"issue":"9","key":"zoi230916r28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1177\/0269881120919970","article-title":"Does cannabis complement or substitute alcohol consumption? a systematic review of human and animal studies.","volume":"34","author":"Risso","year":"2020","journal-title":"J Psychopharmacol"},{"key":"zoi230916r1","unstructured":"Parliament of Canada. Cannabis Act (S.C. 2018, c. 16). Published 2018. Accessed March 22, 2023. https:\/\/laws-lois.justice.gc.ca\/eng\/acts\/c-24.5\/"},{"key":"zoi230916r3","unstructured":"Legislative summary of Bill C-46. Accessed March 29, 2023. https:\/\/lop.parl.ca\/sites\/PublicWebsite\/default\/en_CA\/ResearchPublications\/LegislativeSummaries\/421C46E"},{"key":"zoi230916r17","unstructured":"Canadian Institute for Health Information. Hospital stays for harm caused by substance use\u2014appendices to indicator library, March 2021. Accessed November 14, 2022. https:\/\/www.cihi.ca\/en\/indicators\/hospital-stays-for-harm-caused-by-substance-use"},{"key":"zoi230916r18","unstructured":"MHASEF Research Team. Mental health and addictions system performance in Ontario: a baseline scorecard. 2018. Accessed March 21, 2022. https:\/\/www.ices.on.ca\/publications\/research-reports\/mental-health-and-addictions-system-performance-in-ontario-a-baseline-scorecard\/"},{"key":"zoi230916r19","unstructured":"Statistics Canada. Population Centre and Rural Area Classification 2016. Accessed July 31, 2023. https:\/\/www.statcan.gc.ca\/en\/subjects\/standard\/pcrac\/2016\/introduction"},{"key":"zoi230916r20","unstructured":"Canadian Institute for Health Information. Measuring health inequalities: a toolkit: area-level equity stratifiers using PCCF and PCCF+. Published 2018. Accessed July 31, 2023. https:\/\/www.cihi.ca\/sites\/default\/files\/document\/toolkit-area-level-measurement-pccf-en.pdf"},{"key":"zoi230916r21","unstructured":"Government of Canada. Canadian cannabis survey 2021: summary. Accessed March 22, 2023. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/research-data\/canadian-cannabis-survey-2021-summary.html"},{"key":"zoi230916r22","unstructured":"Government of Canada. Canadian Alcohol and Drugs Survey (CADS): summary of results for 2019. Accessed March 22, 2023. https:\/\/www.canada.ca\/en\/health-canada\/services\/canadian-alcohol-drugs-survey\/2019-summary.html"},{"key":"zoi230916r24","unstructured":"Public Safety Canada. Annual national data report to inform trends and patterns in drug-impaired driving. Published 2021. Accessed April 19, 2023. https:\/\/www.publicsafety.gc.ca\/cnt\/rsrcs\/pblctns\/2021-did-fad\/index-en.aspx#s42"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2808961\/myran_2023_oi_230916_1692894113.11369.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T15:04:37Z","timestamp":1694012677000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2808961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.31551","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]}}}